Author
PELOSO, GINA - Massachusetts General Hospital | |
AUER, PAUL - University Of Wisconsin | |
BIS, JOSHUA - University Of Washington | |
VOORMAN, AREND - University Of Washington | |
MORRISON, ALANNA - University Of Texas | |
STITZIEL, NATHAN - Washington University | |
BRODY, JENNIFER - University Of Washington | |
KHETARPAL, SUMEET - University Of Pennsylvania | |
CROSBY, JACY - University Of Texas | |
FORNAGE, MYRIAM - University Of Texas | |
ISAACS, AARON - Erasmus Medical Center | |
JAKOBSDOTTIR, JOHANNA - Icelandic Heart Association | |
FEITOSA, MARY - Washington University | |
DAVIES, GAIL - University Of Edinburgh | |
HUFFMAN, JENNIFER - University Of Edinburgh | |
MANICHAIKUL, ANI - University Of Virginia | |
DAVIS, BRIAN - University Of Texas | |
LOHMAN, KURT - Wake Forest University | |
JOON, ARON - University Of Texas | |
SMITH, ALBERT - University Of Iceland | |
GROVE, MEGAN - University Of Texas | |
ZANONI, PAOLO - University Of Pennsylvania | |
REDON, VALESKA - University Of Pennsylvania | |
DEMISSIE, SERKALEM - Boston University | |
LAWSON, KIM - University Of Texas | |
PETERS, ULRIKE - Fred Hutchinson Cancer Research Center | |
CARLSON, CHRISTOPHER - Fred Hutchinson Cancer Research Center | |
JACKSON, REBECCA - The Ohio State University | |
RYCKMAN, KELLI - University Of Iowa | |
MACKEY, RACHEL - University Of Pittsburgh | |
ROBINSON, JENNIFER - University Of Iowa | |
SISCOVICK, DAVID - University Of Washington | |
SCHREINER, PAMELA - University Of Minnesota | |
MYCHALECKYJ, JOSYF - University Of Virginia | |
PANKOW, JAMES - University Of Minnesota | |
HOFMAN, ALBERT - Erasmus Medical Center | |
UITTERLINDEN, ANDRE - Erasmus Medical Center | |
HARRIS, TAMARA - National Institutes Of Health (NIH) | |
TAYLOR, KENT - Los Angeles Biomedical Research Institute | |
STAFFORD, JEANETTE - Wake Forest University | |
REYNOLDS, LINDSAY - Wake Forest University | |
MARIONI, RICCARDO - University Of Edinburgh | |
DEHGHAN, ABBAS - Erasmus Medical Center | |
FRANCO, OSCAR - Erasmus Medical Center | |
PATEL, ANIRUDDH - Massachusetts General Hospital | |
LU, YINGCHANG - The Icahn School Of Medicine At Mount Sinai | |
HINDY, GEORGE - Lund University | |
GOTTESMAN, OMRI - The Icahn School Of Medicine At Mount Sinai | |
BOTTINGER, ERWIN - The Icahn School Of Medicine At Mount Sinai | |
MELANDER, OLLE - Lund University | |
ORHO-MELANDER, MARJU - Lund University | |
LOOS, RUTH J F - The Icahn School Of Medicine At Mount Sinai | |
DUGA, STEFANO - Universita Degli Studi Di Salerno | |
MERLINI, PIERA ANGELICA - Ospedale Niguarda | |
FARRALL, MARTIN - University Of Oxford | |
GOEL, ANJUL - University Of Oxford | |
ASSELTA, ROSANNA - Universita Degli Studi Di Salerno | |
GIRELLI, DOMINICO - University Of Verona | |
MARTINELLI, NICOLA - University Of Verona | |
SHAH, SVATI - Duke University | |
KRAUS, WILLIAM - Duke University | |
LI, MINGYAO - University Of Pennsylvania | |
RADER, DANIEL - University Of Pennsylvania | |
REILLY, MUREDACH - University Of Pennsylvania | |
MCPHERSON, RUTH - University Of Ottawa | |
WATKINS, HUGH - Merck Research Laboratories | |
ARDISSINO, DIEGO - Hospital Of Parma | |
ZHANG, QUNYUAN - Washington University | |
WANG, JUDY - Washington University | |
TSAI, MICHAEL - University Of Minnesota | |
TAYLOR, HERMAN - University Of Mississippi | |
CORREA, ADOLFO - University Of Mississippi | |
GRISWOLD, MICHAEL - University Of Mississippi | |
LANGE, LESLIE - University Of Edinburgh | |
STARR, JOHN - University Of Edinburgh | |
RUDAN, IGOR - University Of Edinburgh | |
EIRIKSDOTTIR, GUDNY - Icelandic Heart Association | |
LAUNER, LENORE - National Institutes Of Health (NIH) | |
ORDOVAS, JOSE - Jean Mayer Human Nutrition Research Center On Aging At Tufts University | |
LEVY, DANIEL - National Heart, Lung And Blood Institute(NHLBI, NIH) | |
CHEN, Y D IDA - Los Angeles Biomedical Research Institute | |
REINER, ALEXANDER - Fred Hutchinson Cancer Research Center | |
HAYWARD, CAROLINE - University Of Edinburgh | |
POLASEK, OZREN - University Of Split | |
DEARY, IAN - University Of Edinburgh | |
BORECKI, INGRID - Washington University | |
LIU, YONGMEI - Wake Forest University | |
GUDNASON, VILMUNDUR - Icelandic Heart Association | |
WILSON, JAMES - University Of Mississippi | |
VAN DUIJN, CORNELIA - Erasmus Medical Center | |
KOOPERBERG, CHARLES - Fred Hutchinson Cancer Research Center | |
RICH, STEPHEN - University Of Virginia |
Submitted to: The American Journal of Human Genetics
Publication Type: Peer Reviewed Journal Publication Acceptance Date: 1/9/2014 Publication Date: 2/6/2014 Citation: Peloso, G.M., Auer, P.L., Bis, J.C., Voorman, A., Morrison, A.C., Stitziel, N.O., Brody, J.A., Khetarpal, S.A., Crosby, J.R., Fornage, M., Isaacs, A., Jakobsdottir, J., Feitosa, M.F., Davies, G., Huffman, J.E., Manichaikul, A., Davis, B., Lohman, K., Joon, A.Y., Smith, A.V., Grove, M.L., Zanoni, P., Redon, V., Demissie, S., Lawson, K., Peters, U., Carlson, C., Jackson, R.D., Ryckman, K.K., Mackey, R.H., Robinson, J.G., Siscovick, D.S., Schreiner, P.J., Mychaleckyj, J.C., Pankow, J.S., Hofman, A., Uitterlinden, A.G., Harris, T.B., Taylor, K.D., Stafford, J.M., Reynolds, L.M., Marioni, R.E., Dehghan, A., Franco, O.H., Patel, A.P., Lu, Y., Hindy, G., Gottesman, O., Bottinger, E.P., Melander, O., Orho-Melander, M., Loos, R., Duga, S., Merlini, P., Farrall, M., Goel, A., Asselta, R., Girelli, D., Martinelli, N., Shah, S.H., Kraus, W.E., Li, M., Rader, D.J., Reilly, M.P., Mcpherson, R., Watkins, H., Ardissino, D., Zhang, Q., Wang, J., Tsai, M.Y., Taylor, H.A., Correa, A., Griswold, M.E., Lange, L.A., Starr, J.M., Rudan, I., Eiriksdottir, G., Launer, L.J., Ordovas, J.M., Levy, D., Chen, Y., Reiner, A.P., Hayward, C., Polasek, O., Deary, I.J., Borecki, I.B., Liu, Y., Gudnason, V., Wilson, J., Van Duijn, C.M., Kooperberg, C., Rich, S.S. 2014. Association of low-frequency and rare coding-sequence variants with blood lipids and Coronary Heart Disease in 56,000 whites and blacks. The American Journal of Human Genetics. 94:223-232. Interpretive Summary: Blood lipid levels are known cardiovascular risk factors and their levels are defined by a combination of genetic and environmental factors. There is a heated controversy among those who defend the significance of the common genetic variants and those who think that the most important role is played by rare mutations. In this regard, low-frequency coding DNA sequence variants in the proprotein convertase subtilisin/kexin type 9 gene (PCSK9) have been found to lower plasma low-density lipoprotein cholesterol (LDL-C), protect against risk of coronary heart disease (CHD), and have prompted the development of a new class of therapeutics. However, it is uncertain whether this PCSK9 example represents a paradigm or an isolated exception. Therefore, we genotyped >200,000 low-frequency and rare coding sequence variants across the genome in 56,538 individuals (42,208 European ancestry [EA] and 14,330 African ancestry [AA]) and tested these variants for association with low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides. Although we did not identify new genes associated with LDL-C, we did identify four rare mutations in the ANGPTL8 (rs145464906), PAFAH1B2 (rs186808413), COL18A1 (rs114139997) and PCSK7 (rs142953140) genes with large effects on HDL-C and/or triglycerides. However, none of these four variants was associated with risk for CHD, suggesting that examples of low-frequency coding variants with robust effects on both lipids and CHD will be limited. Technical Abstract: Low-frequency coding DNA sequence variants in the proprotein convertase subtilisin/kexin type 9 gene (PCSK9) lower plasma low-density lipoprotein cholesterol (LDL-C), protect against risk of coronary heart disease (CHD), and have prompted the development of a new class of therapeutics. It is uncertain whether the PCSK9 example represents a paradigm or an isolated exception. We used the "Exome Array" to genotype >200,000 low-frequency and rare coding sequence variants across the genome in 56,538 individuals (42,208 European ancestry [EA] and 14,330 African ancestry [AA]) and tested these variants for association with LDL-C, high-density lipoprotein cholesterol (HDL-C), and triglycerides. Although we did not identify new genes associated with LDL-C, we did identify four low-frequency (frequencies between 0.1% and 2%) variants (ANGPTL8 rs145464906 [c.361C>T; p.Gln121*], PAFAH1B2 rs186808413 [c.482C>T; p.Ser161Leu], COL18A1 rs114139997 [c.331G>A; p.Gly111Arg], and PCSK7 rs142953140 [c.1511G>A; p.Arg504His]) with large effects on HDL-C and/or triglycerides. None of these four variants was associated with risk for CHD, suggesting that examples of low-frequency coding variants with robust effects on both lipids and CHD will be limited. |